Sponsor
Puerta de Hierro University Hospital
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Puerta de Hierro University Hospital appears in 30 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
30 shownEffect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY)NCT06285760 · lead sponsor · 2024-03-01
RECRUITINGREACTION-VAD Trial: Remote Exercise Training Via Telemedicine in Patients With Long-Term Ventricular Assist DevicesNCT07611188 · lead sponsor · 2026-05-01
NOT_YET_RECRUITINGImpact of Cardiac Rehabilitation Adapted for Patients With Heart FailureNCT07350941 · lead sponsor · 2026-01-30
NOT_YET_RECRUITINGEffect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection FractionNCT06712030 · lead sponsor · 2025-01-01
NOT_YET_RECRUITINGHeart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world DataNCT07008729 · lead sponsor · 2024-04-24
ACTIVE_NOT_RECRUITINGHypertonic Saline Therapy in Ambulatory Heart Failure Unit.NCT04533997 · lead sponsor · 2021-01-01
COMPLETEDPARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait ReeducationNCT04194762 · lead sponsor · 2019-09-09
UNKNOWNMulticenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO).NCT03426111 · lead sponsor · 2018-04-18
UNKNOWNHIV Eradication Through Cord-blood TransplantationNCT02923076 · lead sponsor · 2016-06-01
UNKNOWNLaparoscopic Gastric Bypass Versus Laparoscopic Banded Gastric Bypass Randomized Prospective Clinical TrialNCT02939664 · lead sponsor · 2016-04-01
ENROLLING_BY_INVITATIONStudy Comparing Two Strategies of Exercise in Breast and Colon Cancer Survivors and Their Impact on FatigueNCT02647398 · lead sponsor · 2016-01-01
COMPLETEDLaparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric BypassNCT02779322 · lead sponsor · 2015-06-01
UNKNOWNReDS-guided Decongestion Strategy in Patients Hospitalized for Heart FailureNCT07484009 · collaborator · 2026-01-29
RECRUITINGHigh Fat Diet for Cardiac Metabolic ReprogrammingNCT06747429 · collaborator · 2026-01-15
RECRUITINGCerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive DisordersNCT06450704 · collaborator · 2025-04-21
RECRUITINGAn International Prospective, Observational, Multi-centre Study on the Duration of Pre-operative Liquid FastingNCT06527703 · collaborator · 2024-11-01
COMPLETEDDesign of Personalised SupplemenTs Based on the Gut MicRobiota Through Artificial Intelligence for Alzheimer's PatientsNCT06199193 · collaborator · 2024-02-01
UNKNOWNMultidimensional Impact of Telemonitoring in Heart Failure (IMPACT-HF)NCT05653726 · collaborator · 2023-11-29
UNKNOWNGroup Version of the UP-A in a Spanish Day Hospital for Adolescents.NCT06894394 · collaborator · 2023-01-01
COMPLETEDZinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.NCT06434753 · collaborator · 2022-10-02
UNKNOWNA Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020NCT05385705 · collaborator · 2022-05-11
TERMINATEDActive Pregnancy Against COVID-19NCT04563065 · collaborator · 2020-08-01
UNKNOWNPortal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)NCT04191044 · collaborator · 2020-01-10
UNKNOWN´Sit Less, Move More' at Work: mHealth Intervention on Office Employees With Diabetes Type 2.NCT04092738 · collaborator · 2019-03-04
UNKNOWNInterhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.NCT03300349 · collaborator · 2017-09-27
COMPLETEDBeta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart FailureNCT02775539 · collaborator · 2016-06-01
UNKNOWNThe International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).NCT02692430 · collaborator · 2016-04-01
UNKNOWNBehavioural Changes in Breast Cancer PatientsNCT01990430 · collaborator · 2013-01-01
UNKNOWNSpanish Atrial Fibrillation And Resynchronization StudyNCT01181414 · collaborator · 2010-10-01
COMPLETEDSelf-expandable Esophageal Stent Versus Balloon Tamponade in Refractory Esophageal Variceal Bleeding.NCT01242280 · collaborator · 2010-01-01
COMPLETEDDrugs studied in this sponsor's trials
6 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Puerta de Hierro University Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
cyclophosphamide1
mirabegron1
pertuzumab1
placebo1
sacubitril / valsartan1
trastuzumab1
cyclophosphamide RxCUI 3002 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
mirabegron RxCUI 1300786 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
pertuzumab RxCUI 1298944 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
sacubitril / valsartan RxCUI 1656339 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
trastuzumab RxCUI 224905 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
collaborator18
lead sponsor12
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.